Abstract:As the Nobel laureate Luigi Pirandello wrote in his novels, identities can be evanescent. Although a quarter of a century has passed since regulatory T cells (Treg) were first described, new studies continue to reveal surprising and contradictory features of this lymphocyte subset. Treg cells are the core of the immunological workforce engaged in the restraint of autoimmune or inflammatory reactions, and their characterization has revealed substantial heterogeneity and complexity in the phenotype and gene expression profiles, proving them to be a most versatile and adaptive cell type, as exemplified by their plasticity in fine-tuning immune responses. Defects in Treg function are associated with several autoimmune diseases, including multiple sclerosis, which is caused by an inappropriate immune reaction toward brain components; conversely, the beneficial effects of immunomodulating therapies on disease progression have been shown to partly act upon the biology of these cells. Both in animals and in humans the pool of circulating Treg cells is a mixture of natural (nTregs) and peripherally-induced Treg (pTregs). Particularly in humans, circulating Treg cells can be phenotypically subdivided into different subpopulations, which so far are not well-characterized, particularly in the context of autoimmunity. Recently, Treg cells have been rediscovered as mediators of tissue healing, and have also shown to be involved in organ homeostasis. Moreover, stability of the Treg lineage has recently been addressed by several conflicting reports, and immune-suppressive abilities of these cells have been shown to be dynamically regulated, particularly in inflammatory conditions, adding further levels of complexity to the study of this cell subset. Finally, Treg cells exert their suppressive function through different mechanisms, some of which—such as their ectoenzymatic activity—are particularly relevant in CNS autoimmunity. Here, we will review the phenotypically and functionally discernible Treg cell subpopulations in health and in multiple sclerosis, touching also upon the effects on this cell type of immunomodulatory drugs used for the treatment of this disease.

FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis

Neuropilin-1 Identifies a New Subpopulation of TGF--Induced Foxp3<SUP>+</SUP> Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation

Identification and Characterization of Foxp3+ Γδ T Cells in Mouse and Human

Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation

Advances in Distinguishing Natural from Induced Foxp3(+) Regulatory T Cells.

FoxP3 in T reg cell biology: a molecular and structural perspective

Foxp3, A Critical Mediator Of Regulatory T-Cell Function, Is Expressed In Subsets Of Myeloid Cells

Advances In Distinguishing Natural From Induced Foxp3(+) Regulatory T Cells

You, Me and Foxp3: Immune Regulation for Two.

FoxP3 in T<sub>reg</sub> cell biology: a molecular and structural perspective

FoxP3 in Treg Cell Biology: a Molecular and Structural Perspective

Regulatory T Cells: the Many Faces of Foxp3

The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases

One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity

Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity

Foxp3 Post-translational Modifications and Treg Suppressive Activity

Foxp3, Regulatory T Cell, and Autoimmune Diseases

Control of Regulatory T Cells and T Helper Cells in Human Diseases: from Bench to Bedside.

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications

FOXP3 exon 2 controls T reg stability and autoimmunity